One of the aims of the project is to determine the current practices of STI service providers in the diagnosis and treatment of common STI in the Philippines.
Country: Philippines (Metro Manila)
Client:National Center for Disease Prevention and Control (NCDPC) – Infectious Disease Office, Department of Health
Duration: August 2011 – February 2012
Description: In the pursuit of providing quality, accessible and affordable treatment, the Department of Health (DOH) is tasked by the World Health Organization (WHO) to continuously revisit and review policies, standards and guidelines based on a rich evidence-base for sexually–transmitted infection (STI) control in the prevention of HIV transmission.
As for STI, the treatment guidelines were reviewed in 2003 by panel of experts and program partners representing various stakeholders for STI and HIV. Recent reports from the field would show that sporadic observations on clinical resistance of common STI causing microorganism have been noted. This observation, although not supported by the vast pieces of evidence, should not be disregarded. To validate these observations, DOH will gather pieces of evidence on resistance of common STI causing agents to current treatment regimes.
This operations research, therefore, aims to:
- determine the current practices of STI service providers in the diagnosis and treatment of common STI in the country;
- review the current treatment recommendations of common STI-causing microorganisms through conduct of population-specific clinic-epidemiologic study and desk review of related studies; and
- provide DOH recommendations to the current STI treatment regimen.
PRIMEX Team:
Dr. Florante P. Magboo – Principal Investigator/Team Leader